Cargando…
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread
Artemisinins are the most rapidly acting of currently available antimalarial drugs. Artesunate has become the treatment of choice for severe malaria, and artemisinin-based combination therapies (ACTs) are the foundation of modern falciparum malaria treatment globally. Their safety and tolerability p...
Autores principales: | Woodrow, Charles J., White, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424521/ https://www.ncbi.nlm.nih.gov/pubmed/27613271 http://dx.doi.org/10.1093/femsre/fuw037 |
Ejemplares similares
-
The threat of artemisinin resistant malaria in Southeast Asia
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2016) -
Artemisinin Resistance Outside of Southeast Asia
por: Rosenthal, Philip J.
Publicado: (2018) -
Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
por: Srimuang, Krongkan, et al.
Publicado: (2016) -
Correction to: Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
por: Srimuang, Krongkan, et al.
Publicado: (2018) -
The spread of chloramphenicol-resistant Neisseria meningitidis in Southeast Asia
por: Batty, Elizabeth M., et al.
Publicado: (2020)